HOME > BUSINESS > Article

Text Size

small

medium

large


Fujifilm to Raise Antiflu Drug Output for Ebola Treatment

Fujifilm to Raise Antiflu Drug Output for Ebola Treatment

   Tokyo, Oct. 20 (Jiji Press)--Fujifilm Corp. said Monday that it will start additional production of favipiravir, an antiflu drug developed by subsidiary Toyama Chemical Co., in mid-November for use in treatment of Ebola patients abroad.
   Favipiravir has yet to be authorized for Ebola treatment, but is said to be possibly effective for the deadly disease.

To read a full story, please click here to find out how to subscribe.

BUSINESS

HEADLINES

POLITICS
Japan to Send Team to N. Korea This Week to Check Progress in Abduction Probe
ECONOMY
Japan, EU Begin 7th Round of EPA Talks in Brussels; Auto Trade among Key Issues
SPORTS
Japan Baseball: Softbank Hawks Advance to Japan Series for 1st Time in 3 Years
OTHER
No. 26 H-2A Rocket, Set to Be Used for Asteroid Probe Launch Nov. 30, Unveiled

AFP-JIJI PRESS NEWS JOURNAL


Photos